🔓
Sign in as a Member to unlock the full view of NBIX. · Full hedge fund list, every line-item carveout, cabinet conflicts, and politicians-trading detail.
Become a Member$29.99/mo already a Member? Sign in →
NBIX

Neurocrine Biosciences, Inc.

Sector: healthcareDrug Manufacturers - Specialty & GenericNASDAQMarket Cap: $12.91B

Neurocrine Biosciences is a biopharmaceutical company focused on neurological and endocrine disorders, with its most significant political signal being $13.9M in 2024 doctor payments and a $1,001-$15,000 stock holding by Donald J. Trump.

Next filing → your inbox
Govt Dependence
5/100
Regulatory Density
85/100
Lobbying Intensity
0/100
Political Signal
NEUTRAL

BusinessWhat NBIX does

Neurocrine Biosciences develops and commercializes pharmaceuticals for neurological, psychiatric, and endocrine disorders. Its revenue is driven by products like Ingrezza for tardive dyskinesia and Ongentys for Parkinson's disease, with no federal contract revenue material to its $12.9B market cap. The company engages in extensive doctor payment programs, totaling $13.9M in 2024 across 98,411 payments.

12 months past · 3 months futureNBIX activity timeline

$191$155$119 DecJan '26FebMarAprMayJunJulAugSepOctNovDecJan '27Feb ↓ PAST — recorded activity ↑ FUTURE — scheduled markups · pending votes TODAY · Nov 17 $185.50 hi $123.10 lo $165.31 CONGRESS 30 INSIDERS 0 13F FUNDS 30 BILLS 30 AQR Capital Management · OPENED $651M · 2026-03-31AQR Capital Management · - $643M · 2026-06-30Two Sigma Investments · + $403M · 2026-03-31Renaissance Technologies · holds $394M · 2026-06-30Two Sigma Investments · - $350M · 2026-06-30Renaissance Technologies · holds $326M · 2026-09-30Renaissance Technologies · + $319M · 2026-03-31Renaissance Technologies · - $318M · 2025-12-31Millennium Management · + $164M · 2026-03-31Two Sigma Investments · + $140M · 2025-12-31Millennium Management · - $63M · 2025-12-31 HR.2001 · passed_one · 2026-07-21 MARKUP · Senate Veterans' Affairs · 2026-11-18MARKUP · Senate Finance · 2026-11-18MARKUP · Senate Health, Education, Labor, and Pensions · 2026-11-18MARKUP · Senate Budget · 2026-11-18MARKUP · Senate Veterans' Affairs · 2026-11-18
Congress
buy sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened + added − trimmed closed holds
Bills
past action (this ticker) upcoming markup (sector) ★ carveout (this ticker)
250 trading days · 0 congressional trades shown · 0 insider buys · 11 13F filings · 1 past bill actions · 5 upcoming markups

Executive Branch ConflictsNBIX held by Trump-administration officials

Lifetime Government AwardsNBIX federal contracts by year

$28M
total awarded · 2017–2021
114
contracts on file
2021
peak year ($11M)
$11M $6M 2017: $237K across 17 contracts $237K 2017 17 contracts 2018: $649K across 44 contracts $649K 2018 44 contracts 2019: $6M across 14 contracts $6M 2019 14 contracts 2020: $10M across 19 contracts $10M 2020 19 contracts 2021: $11M across 20 contracts (peak year) $11M 2021 20 contracts
Top contracts by award amount
$841K Department of Veterans Affairs 2020-01-03 VALBENAZINE
$826K Department of Veterans Affairs 2019-02-21 VALBENAZINE
$807K Department of Veterans Affairs 2019-11-26 VALBENAZINE
$699K Department of Veterans Affairs 2019-09-11 VALBENAZINE 40MG&80MG
$698K Department of Veterans Affairs 2021-04-07 REFILL OF PHARM ITEMS TO MEET CMOPS
5 years · 114 contracts

Smart Money · 13F HoldingsHedge funds holding NBIX

$1.37B
Total NBIX held by tracked 13F funds
7
Funds with NBIX positions
AQR Capital Management $643M -23% 2026-06-30
Two Sigma Investments $350M -32% 2026-06-30
Renaissance Technologies $326M holds 2026-09-30
Bridgewater Associates $35M +39% 2026-06-30
Citadel Advisors $12M -18% 2026-06-30
Millennium Management $2M -99% 2026-06-30
D.E. Shaw & Co. $944K -94% 2026-06-30

Politicians Trading NBIXMembers of Congress with recent NBIX positions

2 politicians traded NBIX across 6 disclosed transactions totaling $97K (last 730 days). Greed score = composite of trade frequency, volume & recency across the politician's entire history (not just NBIX). 0-30 LOW · 30-60 MID · 60+ HIGH.

Congressional TradesWho in Congress is trading NBIX

2025-06-11 Lisa C. McClain R-Michigan · house purchase $1,001 - $15,000 63d late
2025-06-17 Lisa C. McClain R-Michigan · house sale $1,001 - $15,000 57d late
2025-06-11 Lisa C. McClain R-Michigan · house Purchase $1,001 - $15,000 63d late
2025-06-17 Lisa C. McClain R-Michigan · house Sale $1,001 - $15,000 57d late
2024-11-19 Michael T. McCaul R-Texas · house sale $15,001 - $50,000
2024-11-19 Michael T. McCaul R-Texas · house Sale $15,001 - $50,000
2024-08-26 Michael T. McCaul R-Texas · house sale $1,001 - $15,000
2024-08-26 Michael T. McCaul R-Texas · house Sale $1,001 - $15,000
2023-10-27 Michael T. McCaul R-Texas · house sale $15,001 - $50,000
2023-10-27 Michael T. McCaul R-Texas · house sale $50,001 - $100,000
2023-10-27 Michael T. McCaul R-Texas · house Sale $15,001 - $50,000
2023-10-27 Michael T. McCaul R-Texas · house Sale $50,001 - $100,000
30+ trades on file · most recent 2025-08-13

Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock

Stock awards & option exercises

11
stock awards · $9.0M market value
14
option exercises · $4.8M
2026-09-11 GORMAN KEVIN CHARLES Director AWARD 14,343 sh $2.2M
2026-09-11 BENEVICH ERIC Chief Commercial Officer AWARD 6,275 sh $980K
2026-09-11 Gano Kyle Chief Executive Officer AWARD 6,275 sh $980K
2026-09-11 ABERNETHY MATT Chief Financial Officer AWARD 5,020 sh $784K
2026-09-11 Delaet Ingrid Chief Regulatory Officer AWARD 4,483 sh $700K
2026-09-11 Lippoldt Darin Chief Legal Officer AWARD 4,483 sh $700K
2026-09-11 Keswani Sanjay Chandru Chief Medical Officer AWARD 3,914 sh $611K
2026-09-11 Onyia Jude Chief Scientific Officer AWARD 3,587 sh $560K
For NBIX, executives receive stock primarily as compensation rather than via open-market purchases — typical for established large-cap firms.

Bills Affecting NBIXLive legislation impacting this stock

Political ProfileWhere NBIX sits in Washington

[object Object]

STRUCTURAL: High regulatory density (85) due to healthcare sector and doctor payment volume ($13.9M in 2024), but no lobbying spend or donation patterns. EVIDENTIARY: Executive branch exposure shows Donald J. Trump holds $1,001-$15,000 in stock (get_executive_branch_exposure.by_ticker[0].holdings[1]), and one congressional trader (M001136) made purchase and sale transactions in June 2025. Net: Limited direct political engagement, with mixed but weak signals.

Regulatory ExposureThreats & opportunities

Regulatory threats

  • Increased scrutiny on doctor payments under Sunshine Act
    CMS
    "get_political_influence.doctor_payments shows $13.9M in 2024 across 98,411 payments, potentially drawing regulatory attention"
  • Drug pricing legislation impacting revenue
    Congress, HHS
    "Recent bill_impacts array shows 8 healthcare bills with estimated revenue impacts up to $6.06M"

Regulatory opportunities

  • Veterans Affairs contracts for drug supply
    Department of Veterans Affairs
    "get_government_precedent.federal_contracts_summary shows 11 contracts totaling $6.65M obligation"
  • Potential favorable policy for neurological treatments
    FDA, Congress
    "Recent bill_impacts array includes multiple healthcare bills, some may be supportive"
Member intelligence layer

Live signals + predictions for NBIX — for Founders

The free page above gives you the public record. Members see the real-time intelligence layer on top of it:

Become a Founder · $29.99/mo Locked rate forever · cancel anytime

Frequently AskedAbout NBIX & political exposure

Does Neurocrine Biosciences, Inc. (NBIX) hold federal contracts?
Yes. Neurocrine Biosciences, Inc. has 114 federal contract awards totaling $28,473,116, primarily from agencies including Department of Justice, Department of Veterans Affairs. See full contract list and amounts on this page.
Which Trump cabinet officials own NBIX stock?
1 Trump cabinet members or senior White House staff have disclosed holdings in NBIX on their OGE 278 financial disclosures, including Donald J. Trump. See the Cabinet Conflicts panel for details.
Has Congress traded NBIX stock?
60 congressional trades by 5 unique members of Congress, most recently on 2025-06-17. See the Congressional Trading panel for politician-by-politician breakdown.
What is NBIX political risk profile?
Government dependence: 5/100. Lobbying intensity: 0/100. Political signal: neutral. Donor party split: R 0% / D 0%.
How does GovGreed track NBIX political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. NBIX data is updated daily from these official federal sources.